Filings (90d)
Other insiders active in the same sector
No other insider has filed at Hilary Kramer's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $55.93M in RVMD purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hilary Kramer?
Hilary Kramer is a corporate insider, tracked as Director of GT Biopharma, Inc. (GTBP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Hilary Kramer last file a Form 4?
The only primary Form 4 on record is dated 4 September 2025.